Applications
Recherche / filtres d’applications
| Classification | Nom de document | Connexion | Code produit | Colonne | |
| Antibodies, Antibody-Drug-Conjugates | Native IEX-MS analysis of monoclonal antibodies using YMC Accura BioPro IEX SF columns | NISTmAb Trastuzumab | SF00S05-15Q1PTC | YMC Accura BioPro IEX SF | |
| Antibodies, Antibody-Drug-Conjugates | Drug-to-Antibody Ratio (DAR) analysis of ADC | Cysteine-conjugated ADC mimic | BHB00S04-1046WT | BioPro HIC BF | |
| Antibodies, Antibody-Drug-Conjugates | Antibody drugs by HIC using Isopropanol | Adalimumab (Humira®) Brentuximab Pembrolizumab (Keytruda®) Reslizumab (Cinqaero®) | BHB00S04-1046WT | BioPro HIC BF | |
| Antibodies, Antibody-Drug-Conjugates | Monoclonal antibody (MAb) and its aggregates | Humanized monoclonal IgG1 | DLM25S03-3046WT | YMC-SEC MAB | |
| Antibodies, Antibody-Drug-Conjugates | Monoclonal antibody fragments (papain digestion) | Humanized monoclonal IgG1 | DLM25S03-3046WT | YMC-SEC MAB | |
| Antibodies, Antibody-Drug-Conjugates | Antibody-Drug Conjugate (ADC) | Cysteine conjugated ADC mimic | DLM25S03-3046WT | YMC-SEC MAB | |
| Antibodies, Antibody-Drug-Conjugates | Antibody drugs by HIC using ammonium sulphate | Bevacizumab (Avastin®) Rituximab (MabThera®) NIST mAb Trastuzumab (Herceptin®) Adalimumab (Humira®) | BHB00S04-1046WT | BioPro HIC BF | |
| Antibodies, Antibody-Drug-Conjugates | Antibody drugs by HIC using sodium chloride | Bevacizumab (Avastin®) Rituximab (MabThera®) NIST mAb Trastuzumab (Herceptin®) Adalimumab (Humira®) | BHB00S04-1046WT | BioPro HIC BF | |
| Antibodies, Antibody-Drug-Conjugates | ADC Analysis with LC-MS compatible mobile phases | Cysteine-conjugated ADC mimic | TB30SP9-05Q1PT | YMC-Triart Bio C4 | |
| Antibodies, Antibody-Drug-Conjugates | Analysis of Bevacizumab (Avastin®) and its aggregates and fragments | Bevacizumab (Avastin®) | DLM25S03-3046WT | YMC-SEC MAB | |
| Carbohydrates | Maltooligosaccharides (G11 ～ G15) | Maltoundecaose (G11) Maltododecaose (G12) Maltotridecaose (G13) Maltotetradecaose (G14) Maltopentadecaose (G15) | PB12S05-2546WT | YMC-Pack Polyamine II | |
| Carbohydrates | Sugar alcohols | Glycerol Erythritol Xylitol Ribitol Arabitol Sorbitol Mannitol Maltitol Inositol | PB12S05-2546WT | YMC-Pack Polyamine II | |
| Carbohydrates | Monosaccharides | Rhamnose Fucose Xylose Fructose Mannose Glucose Galactose | PB12S05-2546WT | YMC-Pack Polyamine II | |
| Carbohydrates | Monosaccharides and disaccharides | Fructose Glucose Sucrose Maltose Lactose | PB12S05-2546WT | YMC-Pack Polyamine II | |
| Carbohydrates | Pyridylamino (PA)-Sugar chains | PA-Sugar Chain 014 PA-Sugar Chain 001 PA-Sugar Chain 002 | AA12S05-1546WT | YMC-Pack ODS-A | |
| Carbohydrates | Monosaccharides and disaccharides | Fructose Glucose Sucrose Maltose Lactose | PB12S05-2546WT | YMC-Pack Polyamine II | |
| Carbohydrates | Pyridylamino (PA)-Sugar chains | PA-Sugar Chain 014 PA-Sugar Chain 001 PA-Sugar Chain 002 | AA30S05-1546WT | YMC-Pack ODS-A | |
| Carbohydrates | Monosaccharides and disaccharides | Fructose Glucose Sucrose Maltose Lactose | PB12S05-2546WT | YMC-Pack Polyamine II | |
| Carbohydrates | Pyridylamino (PA)-Sugar chains | PA-Sugar Chain 014 PA-Sugar Chain 001 PA-Sugar Chain 002 | AQ12S05-1546WT | YMC-Pack ODS-AQ | |
| Carbohydrates | Unsaturated chondro-disaccharides | ΔDi-0S ΔDi-6S ΔDi-4S ΔDi-diSD ΔDi-diSE ΔDi-triS | NH12S05-2546WT | YMC-Pack NH2 |
